Style | Citing Format |
---|---|
MLA | Najafipour A, et al.. "Mtx-Loaded Dual Thermoresponsive and Ph-Responsive Magnetic Hydrogel Nanocomposite Particles for Combined Controlled Drug Delivery and Hyperthermia Therapy of Cancer." Molecular Pharmaceutics, vol. 18, no. 1, 2021, pp. 275-284. |
APA | Najafipour A, Gharieh A, Fassihi A, Sadeghialiabadi H, Mahdavian AR (2021). Mtx-Loaded Dual Thermoresponsive and Ph-Responsive Magnetic Hydrogel Nanocomposite Particles for Combined Controlled Drug Delivery and Hyperthermia Therapy of Cancer. Molecular Pharmaceutics, 18(1), 275-284. |
Chicago | Najafipour A, Gharieh A, Fassihi A, Sadeghialiabadi H, Mahdavian AR. "Mtx-Loaded Dual Thermoresponsive and Ph-Responsive Magnetic Hydrogel Nanocomposite Particles for Combined Controlled Drug Delivery and Hyperthermia Therapy of Cancer." Molecular Pharmaceutics 18, no. 1 (2021): 275-284. |
Harvard | Najafipour A et al. (2021) 'Mtx-Loaded Dual Thermoresponsive and Ph-Responsive Magnetic Hydrogel Nanocomposite Particles for Combined Controlled Drug Delivery and Hyperthermia Therapy of Cancer', Molecular Pharmaceutics, 18(1), pp. 275-284. |
Vancouver | Najafipour A, Gharieh A, Fassihi A, Sadeghialiabadi H, Mahdavian AR. Mtx-Loaded Dual Thermoresponsive and Ph-Responsive Magnetic Hydrogel Nanocomposite Particles for Combined Controlled Drug Delivery and Hyperthermia Therapy of Cancer. Molecular Pharmaceutics. 2021;18(1):275-284. |
BibTex | @article{ author = {Najafipour A and Gharieh A and Fassihi A and Sadeghialiabadi H and Mahdavian AR}, title = {Mtx-Loaded Dual Thermoresponsive and Ph-Responsive Magnetic Hydrogel Nanocomposite Particles for Combined Controlled Drug Delivery and Hyperthermia Therapy of Cancer}, journal = {Molecular Pharmaceutics}, volume = {18}, number = {1}, pages = {275-284}, year = {2021} } |
RIS | TY - JOUR AU - Najafipour A AU - Gharieh A AU - Fassihi A AU - Sadeghialiabadi H AU - Mahdavian AR TI - Mtx-Loaded Dual Thermoresponsive and Ph-Responsive Magnetic Hydrogel Nanocomposite Particles for Combined Controlled Drug Delivery and Hyperthermia Therapy of Cancer JO - Molecular Pharmaceutics VL - 18 IS - 1 SP - 275 EP - 284 PY - 2021 ER - |